Current report No. 22/2022 – Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company’s share in the stock exchange trading

Current report No. 22/2022
Date prepared: 18/07/2022
Abbreviated name of the issuer: CELON PHARMA S.A.
Subject: Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company’s share in the stock exchange trading
Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information
Content of the report:
The Management Board of Celon Pharma S.A. (the “Company”) hereby announces that on July 18, 2022 the Central Securities Depository of Poland (“KDPW”) made a decision to assimilate 5,000 ordinary C-series bearer shares on July 22, 2022, registered under the ISIN PLCLNPH00080 code, with the Company’s shares in the stock exchange trading, registered under the PLCLNPH00015 code.
Therefore, the condition for the introduction of the aforementioned 5,000 C series shares to trading on the primary market, specified in the Resolution of the Management Board of the Warsaw Stock Exchange, of which the Company informed in its current report No. 21/2022 of July 15, 2022, has been met.